8-KOther EventsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Corporate Update (Aug 10, 2012)

Filed August 10, 2012For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) has filed an 8-K report on August 10, 2012, to update its previous filings regarding the strategic decision to divest its laboratory workstations business, a segment previously part of its Laboratory Products and Services division. This business has been officially reclassified as discontinued operations, a move that does not impact the company's previously reported net income or earnings per share. The company anticipates completing the sale of this non-core asset by June 2013, signaling a focus on optimizing its business portfolio. This filing primarily serves to formally acknowledge and reflect this reclassification in updated sections of the company's 2011 Form 10-K. Investors should note that while this report addresses the discontinued operations, it does not incorporate any subsequent events or developments beyond the filing date of the 2011 10-K, and therefore should be read in conjunction with TMO's more recent SEC filings for the most current information.

Key Highlights

  • 1Thermo Fisher Scientific is divesting its laboratory workstations business, identified as non-core.
  • 2The laboratory workstations business has been reclassified as discontinued operations.
  • 3The company expects to complete the sale of this business by June 2013.
  • 4This reclassification has no impact on historical reported net income or earnings per share.
  • 5Exhibit 99.1 updates specific sections of the 2011 Form 10-K to reflect the discontinued operations.
  • 6The report emphasizes that Exhibit 99.1 does not include events or updates since the original 2011 10-K filing date and should be read with subsequent filings.
  • 7The filing also includes forward-looking statements and directs investors to 'Risk Factors' in the Q2 2012 10-Q for potential risks and uncertainties.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally report and update previous filings to reflect the reclassification of Thermo Fisher Scientific's laboratory workstations business as discontinued operations, as part of a strategy to exit a non-core segment.

No, the company states that the reclassification of the laboratory workstations business as discontinued operations has had no effect on its historical reported net income or earnings per share. The financial results of this business will be reported separately going forward.

Thermo Fisher Scientific expects to complete the transaction to sell its laboratory workstations business by June 2013.

Investors should be aware that Exhibit 99.1 updates certain sections of the 2011 Form 10-K to reflect the discontinued operations. However, it does not include any information on events or changes that have occurred since the original filing date of the 2011 10-K. Therefore, it is crucial to read this exhibit in conjunction with Thermo Fisher's more recent SEC filings.